WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018081442) POLYOXOMETALATE COMPLEXES AND USES IN MANAGING CANCER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/081442 International Application No.: PCT/US2017/058563
Publication Date: 03.05.2018 International Filing Date: 26.10.2017
IPC:
B32B 21/02 (2006.01) ,C09K 3/14 (2006.01) ,C09D 5/08 (2006.01)
Applicants: EMORY UNIVERSITY[US/US]; Office of Technology Transfer 1599 Clifton Road NE, 4th Floor Atlanta, Georgia 30322, US
Inventors: SONG, Jie; US
NIE, Shuming; US
HILL, Craig; US
Agent: MASON, James C.; US
FRITTS, Laura; US
ISAACS, Randi; US
SHERER, Todd; US
Priority Data:
62/413,40426.10.2016US
62/469,34009.03.2017US
Title (EN) POLYOXOMETALATE COMPLEXES AND USES IN MANAGING CANCER
(FR) COMPLEXES DE POLYOXOMÉTALLATE ET LEURS UTILISATIONS DANS LA PRISE EN CHARGE DU CANCER
Abstract: front page image
(EN) The disclosure relates polyoxometalate complexes and uses in the management, treatment, or prevention of cancer. In certain embodiments, the polyoxometalate complexes comprise polydentate oxygen bridging ligands such as those of the following formula: [POM{(OCH2)3CX}2], [M6O13{(OCH2)3CX}2], [V6O13{(OCH2)3CX}2], salts, or derivatives thereof wherein POM is a polyoxometalate, M is a metal, and X is defined herein. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising polyoxometalate complexes disclosed herein.
(FR) L'invention concerne des complexes de polyoxométallate et leurs utilisations dans la prise en charge, le traitement ou la prévention du cancer. Dans certains modes de réalisation, les complexes de polyoxométallate comprennent des ligands de pontage à l'oxygène polydentés tels que ceux de formule suivante : [POM{(OCH2)3CX}2], [M6O13{(OCH2)3CX}2], [V6O13{(OCH2)3CX}2], des sels ou des dérivés de ces derniers, POM étant un polyoxométallate, M étant un métal et X étant défini dans la description. Dans certains modes de réalisation, l'invention concerne des compositions pharmaceutiques comprenant des complexes de polyoxométallate décrits dans la description.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)